Estancia La Jolla Hotel
La Jolla, California


SYMPOSIUM INFORMATION

>General Information
>Faculty
>Program/Schedule
>Accreditation
>Registration
>Hotel Reservations

 

Sponsored by:

UC San Diego Sulpizio Cardiovascular Center

Endorsed by:

American College of Cardiology



Arizona and California Chapters

 

PROGRAM / SCHEDULE

6:30-8:00am Registration/Coffee

7:00-8:00am
Product Theatre Breakfast (Non-CME)
Support provided by Janssen

8:05-8:15am
Introductions, Welcome and Overview
Drs. Lori Daniels and Alan Maisel

SESSION I
Acute Coronary Syndrome
Alan Maisel, MD, (Moderator)

8:15-8:45am
State of the Art Lecture - hsTn in Acute Coronary Syndrome
David Morrow, MD

8:45-8:55am
hsTn Experience in the USA
Lori Daniels, MD

8:55-9:05am
hsTn in the Emergency Department
Frank Peacock, MD

9:05-9:15am
hsTn in Cardiovascular Disease Prevention
Christopher deFilippi, MD

9:15-9:55am
Acute Coronary Syndrome Case Presentations/Panel
Drs. Maisel, Jaffe, Daniels, Peacock, deFilippi and Wu

9:55-10:25am Break/Visit Exhibits

SESSION II
Biomarker Guided Therapy
Lori Daniels, MD (Moderator)

10:25-11:05am
DEBATE
Biomarker Guided Heart Failure Therapy
Lori Daniels, MD (Moderator)

   10:25-10:30am Introduction

   10:30-10:40am PRO: Neuropeptides, ST2 - Gregg Fonarow, MD

   10:40-10:50am CON: Neuropeptides, ST2 - Peter McCullough, MD

   10:50-10:55am PRO: Rebuttal - Gregg Fonarow, MD

   10:55-11:00am CON: Rebuttal - Peter McCullough, MD

   11:00-11:05am Debate Conclusion/Questions - Lori Daniels, MD

11:05-11:15am
Potassium as a Treatable Biomarker in Cardiovascular Disease:
New Keys to Hyperkalemia
Nicholas Wettersten, MD

11:15-11:30pm
PCSK9 Inhibitors and Modulators
Pam Taub, MD

11:30-11:45am
International Normalized Ratio (INR) as a Biomarker - Anticoagulation in
AFib, Heart Failure and Cardiovascular Disease
Daniel Blanchard, MD

11:45-12:10pm
Heart Failure Case Presentations and Panel
Drs. Wettersten, Elkayam, Fonarow, Anand and Adler

12:10-1:30pm Lunch

SESSION III
Diabetes, Women's CVD, and Modern Medicine
Uri Elkayam, MD (Moderator)

1:30-1:45pm
Cardiologists and HbA1c: Novel Diabetes Drugs and the Cardiologist as Diabetician
Gregg Fonarow, MD

1:45-2:15pm
Keynote Lecture
Women's Heart Disease
C. Noel Bairey Merz, MD

2:15-2:30pm
Breast Arterial Calcification: A Women's Biomarker for the Future
Lori Daniels, MD

2:30-2:45pm
Wearable Devices for Heart Disease, Sleep Apnea and Health
Jia Shen, MD

2:45-3:00pm
Cardiomems: Incorporating a Pulmonary Artery Device and Biomarkers in
Outpatients with Heart Failure
Howie Tran, MD

3:00-3:15pm
INR as a Biomarker - Part 2:
Left Atrial Appendage Occlusion Devices for
Doing Away with INR
Jonathan Hsu, MD

3:15-3:45pm Coffee Break/Visit Exhibits

SESSION IV
Biomarkers in Arrhythmias, Heart Failure, and Pulmonary Arterial
Alan Maisel, MD (Moderator)

3:45-4:00pm
Advanced Therapies in Heart Failure
Eric Adler, MD

4:00-4:10pm
Biomarkers in the Age of Sacubitril/Valsartan
Alan Maisel, MD

4:10-4:35pm
Biomarkers and Arrhythmias/Devices
Ulrika Birgersdotter-Green, MD

4:35-4:50pm
Biomarkers and Treatment in Pulmonary Arterial Hypertension
Marcus Anthony Urey, MD

4:50-5:00pm
Concluding Remarks
Drs. Lori Daniels and Alan Maisel